相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differing impact of clinical factors on the risk of fracture in younger and older women in the general population and an osteoporosis clinic population
Rosa Lauppe et al.
ARCHIVES OF OSTEOPOROSIS (2019)
Hip fracture risk and safety with alendronate treatment in the oldest-old
K. F. Axelsson et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control
Linda Karlsson et al.
ARCHIVES OF OSTEOPOROSIS (2017)
THE TREATMENT GAP AFTER FRACTURE IN OSTEOPOROSIS PATIENTS IN SWEDEN
A. Spangeus et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The annual number of hip fractures in Sweden will double from year 2002 to 2050
Bjorn E. Rosengren et al.
ACTA ORTHOPAEDICA (2014)
Trends in Fracture Incidence: A Population-Based Study Over 20 Years
Shreyasee Amin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Management of osteoporosis of the oldest old
R. Rizzoli et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
Alison Avenell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy
R. Lindsay et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments
Charles A. Inderjeeth et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
Adherence to treatment of primary osteoporosis and its association to fractures-the Swedish Adherence Register Analysis (SARA)
E. Landfeldt et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Osteoporosis: burden, health care provision and opportunities in the EU
O. Ström et al.
Archives of Osteoporosis (2011)
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
A. Abelson et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Effectiveness of bisphosphonate therapy in a community setting
Adrianne C. Feldstein et al.
BONE (2009)
Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures
Willemijn M. Meijer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Benefit of adherence with bisphosphonates depends on age and fracture type: Results from an analysis of 101,038 new bisphosphonate users
Jeffrey R. Curtis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
V. Rabenda et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures
S. Morin et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Ten years' experience with alendronate for osteoporosis in postmenopausal women
HG Bone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mortality, disability, and nursing home use for persons with and without hip fracture: A population-based study
CL Leibson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)
Epidemiology and outcomes of osteoporotic fractures
SR Cummings et al.
LANCET (2002)
Long-term risk of osteoporotic fracture in Malmo
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2000)
分享论文
